Home » Results From Trial Support Expanding Approval of Defibrillators
Results From Trial Support Expanding Approval of Defibrillators
According to Millennium Research Group … growth in the $2 billion U.S. cardiac resynchronization therapy defibrillator market will be supported by the expanded approval of Boston Scientific’s chronic resynchronization therapy defibrillators in New York Heart Association class I and II patients.
Triangle Business Journal
Triangle Business Journal
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May